October 04, 2024 07:12 GMT
Rossini (ROSINI: B3/B/B): Recordati Acquisition
HEALTHCARE
- Recordati (51.82% owned by Rossini) pays $825m to acquire Enjaymo from Sanofi
- Additional $250m milestone payments
- Annual sales $100m for 12 months to August
- Expected Peak Annual sales $250-300m
- Funded by existing cash & bank facilities
- Recordati's leverage will go to 2.4-2.5x and fall to 2.0x 2025 according to the company's press release
49 words